Shopping Cart
- Remove All
- Your shopping cart is currently empty
HPK1-IN-29 is a potent inhibitor of hematopoietic progenitor kinase 1 (HPK1), a negative regulator of the activation response of dendritic cells (DCs), T cells, and B cells. HPK1-IN-29 enhances anti-tumor immunity in humans and shows potential for studying immune-related diseases, particularly tumors.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | 2.033 € | 6-8 weeks | |
50 mg | 2.645 € | 6-8 weeks | |
100 mg | 3.344 € | 6-8 weeks |
Description | HPK1-IN-29 is a potent inhibitor of hematopoietic progenitor kinase 1 (HPK1), a negative regulator of the activation response of dendritic cells (DCs), T cells, and B cells. HPK1-IN-29 enhances anti-tumor immunity in humans and shows potential for studying immune-related diseases, particularly tumors. |
Molecular Weight | 489.45 |
Formula | C26H18F3N5O2 |
Cas No. | 2699604-50-5 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.